Key facts
- This page summarizes Thomas D. Salus's Form 3 filing for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 16 Apr 2025, 16:37.
Thomas D. Salus - 14 Apr 2025 Form 3 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)
- Reporting relationship
- Chief Legal & Administration
- Issuer ticker
- LFCR
- Reported as of
- 14 Apr 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 16 Apr 2025, 16:37:56 UTC
- Next SEC filing
- 10 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Rebecca Hilt, Attorney-In-Fact for Thomas D Salus
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Thomas D. Salus filed Form 3 for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) on 16 Apr 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LFCR
holding
No Security beneficially owned
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 14 Apr 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.